Michalis Efremidis

Safety of pulsed field ablation in more than 17,000 patients with atrial fibrillation in the MANIFEST-17K study

Emmanuel Ekanem, Petr Neužil, Tobias Reichlin et al. · Nature Medicine · 2024 · 308 citations · Full text

CHADS2 and CHA2DS2-VASc scores as predictors of left atrial ablation outcomes for paroxysmal atrial fibrillation

Κonstantinos P. Letsas, Michalis Efremidis, Spyridon Deftereos et al. · EP Europace · 2013 · 97 citations · Full text

Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors

Κonstantinos P. Letsas, Michalis Efremidis, Stavros P. Kounas et al. · Clinical Research in Cardiology · 2008 · 81 citations

Therapeutic Drug Monitoring, Hypertension, Cardiovascular Disease +7

Uric acid elevation in atrial fibrillation.

Panagiotis Korantzopoulos, Filippatos Gs, Markou et al. · PubMed · 2010 · 81 citations

Ablation of atrial fibrillation in patients with heart failure: reversal of atrial and ventricular remodelling.

Michalis Efremidis, Antonios Sideris, Sotirios Xydonas et al. · PubMed · 2008 · 52 citations